Ataxia
44
10
10
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
2 terminated out of 44 trials
91.7%
+5.1% vs benchmark
2%
1 trials in Phase 3/4
5%
1 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 22 completed trials
Clinical Trials (44)
Can Acute Photobiomodulation Improve Balance and Cognition in Individuals With Ataxia: a Pilot Feasibility Placebo Randomized Controlled Trial.
Home Exercise for Individuals With Neurodegenerative Disease
Digital Patient Engagement in Technology-Supported Neurorehabilitation
Perceptual Decision Making Under Conditions of Visual Uncertainty
Impact of Foot Orthoses on Gait in Individuals With Ataxia
"Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis"
Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
RFC1 Natural History Study
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
Effects of Cerebellar tACS-iTBS in Ataxia
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)
Home-based Gait and Balance Training in Patients With Movement Disorders
Neuroimmunology Registry and Biobank
Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises
Validation of Bulbicam for Parkinson- and Ataxia-patients
A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
Teleassessment in Ataxic Multiple Sclerosis
Rehabilitation Program on Genetic and Degenerative Ataxia